The nano-drug with the dual advantages of targeted drug delivery and controlled drug release has become a research hotspot for new antitumor drugs due to its unique properties.
Alzheimers disease(AD)is an incurable neurodegenerative disease.To improve the diagnostic level of AD is essential to early treatment and effectively utilizes disease-modifying drugs.
A lysosome-targeting dual-functional fluorescent probe was rationally designed and developed for imaging intracellular lysosomal viscosity and beta-amyloid.